Fennec Pharmaceuticals Inc. (FENC) has filed its DEF 14A ahead of the April 28 annual meeting, detailing corporate governance and shareholder proposals.

Fennec Pharmaceuticals Inc. (FENC) submitted its DEF 14A filing, related to the annual meeting scheduled for April 28. This filing typically contains important information regarding corporate governance and potential shareholder proposals. The DEF 14A is required by the SEC and provides insight into the company's management and financial decisions. Such filings can impact investor sentiment and stock performance based on disclosed information.

Fennec Pharmaceuticals (FENC) Files DEF 14A for April 28 Meeting

AI Summary

Related News

Oakland Airport (OAK) Can Use ‘San Francisco’ in Settlement Agreement

Citadel Securities (CITA) Expands in Asia with New Hires

Midland States Bancorp (MOSB) Form 144 Filed on April 28, 2023

Zentalis Pharmaceuticals (ZNTL) Files DEF 14A for April 28 Meeting